The Online Investor
ELOS Buyback image

Syneron Medical Ltd. Buyback

OLI recorded this information on 12/1/2014

Company: Syneron Medical Ltd.
Buyback: ELOS buyback
$Amount Authorized: $20,000,000
Buyback Details: Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, today announced that its Board of Directors has authorized a share repurchase program of up to $20 million of Syneron's ordinary shares.

Syneron Medical designs, develops and markets innovative aesthetic medical products based on Co.'s proprietary ELOS technology, which uses the synergy between electrical energy and optical energy to provide aesthetic medical treatments. Co.'s products target non-invasive aesthetic medical procedures, including hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, acne treatment, treatment of leg veins, treatment for the temporary reduction in the appearance of cellulite and thigh circumference, ablation and resurfacing of the skin, laser-assisted lipolysis and topical skin brightening products.
Open the ELOS Page at The Online Investor »

Company Name: 
Syneron Medical Ltd
Stock buyback: 
ELOS buyback
Website: 
www.syneron.com
Sector: 
Medical Instruments & Supplies
 

Open the ELOS Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree ELOS Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Hold (2.00 out of 4)
100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

ELOS Buyback Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2024, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.